Cholangiocarcinomas (CCAs) are hepatobiliary cancers with features of cholangiocyte
differentiation; they can be classified anatomically as intrahepatic CCA (iCCA), perihilar …

Cholangiocarcinoma (CC) is the second most common primary hepatic malignancy after
hepatocellular cancer. CC accounts for approximately 10%‐25% of all hepatobiliary …

Cholangiocarcinoma (CCA) comprises a heterogeneous group of cancers with pathologic
features of biliary tract differentiation, and is presumed to arise from the intra-or extrahepatic …

Choledochal cysts (CC) are a rare congenital cystic dilation of the biliary tract, first described
by Vater and Ezler in 1723. 1 They present primarily in female infants and young children …

Importance Choledochal cysts (CCs) are rare, with risk of infection and cancer. Objective To
characterize the natural history, management, and long-term implications of CC disease …

Choledochal cysts (CCs) are rare bile duct dilatations, intra-and/or extrahepatic, and have
higher prevalence in the Asian population compared to Western populations. Most of the …

Cholangiocarcinoma (CCA) is the second most common primary liver tumour. Intra-hepatic
CCA develops within the liver parenchyma while extrahepatic CCA involves the biliary tree …

The term cholestasis is derived from the Greek word “chole,” which means bile, and “stasis,”
meaning standing still. Cholestasis develops either from a defect in bile synthesis …

The incidence of cancer in choledochal cysts (CCs) in adults was calculated to determine
the timing and need for surgery. In 78 publications (1996–2010), 434 of 5780 reported CCs …

Background The aim of this study was to report a Western experience in the diagnosis and
management of choledochal cyst disease. Results Sixty-seven patients were identified …